Shirley R. Kuhlmann's most recent trade in Collegium Pharmaceutical Inc was a trade of 40,000 Common Stock done at an average price of $24.0 . Disclosure was reported to the exchange on March 4, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Collegium Pharmaceutical Inc | Shirley R. Kuhlmann | EVP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.03 per share. | 04 Mar 2025 | 40,000 | 194,204 (0%) | 0% | 24.0 | 961,200 | Common Stock |
| Collegium Pharmaceutical Inc | Shirley R. Kuhlmann | EVP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 40,000 | 0 | - | - | Stock Option (Right to Purchase) | |
| Collegium Pharmaceutical Inc | Shirley R. Kuhlmann | EVP and General Counsel | Sale of securities on an exchange or to another person at price $ 28.08 per share. | 04 Mar 2025 | 40,000 | 154,204 (0%) | 0% | 28.1 | 1,123,160 | Common Stock |
| Collegium Pharmaceutical Inc | Shirley R. Kuhlmann | EVP and General Counsel | Sale of securities on an exchange or to another person at price $ 28.50 per share. | 04 Mar 2025 | 26,067 | 108,137 (0%) | 0% | 28.5 | 742,946 | Common Stock |
| Collegium Pharmaceutical Inc | Shirley R. Kuhlmann | EVP and General Counsel | Sale of securities on an exchange or to another person at price $ 28.03 per share. | 04 Mar 2025 | 20,000 | 134,204 (0%) | 0% | 28.0 | 560,528 | Common Stock |
| Collegium Pharmaceutical Inc | Shirley R. Kuhlmann | EVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 40,965 | 160,149 (0%) | 0% | 0 | Common Stock | |
| Collegium Pharmaceutical Inc | Shirley R. Kuhlmann | EVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 29,030 | 189,179 (0%) | 0% | 0 | Common Stock | |
| Collegium Pharmaceutical Inc | Shirley R. Kuhlmann | EVP and General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.52 per share. | 10 Feb 2025 | 25,149 | 154,204 (0%) | 0% | 30.5 | 767,547 | Common Stock |
| Collegium Pharmaceutical Inc | Shirley R. Kuhlmann | EVP and General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.52 per share. | 10 Feb 2025 | 9,826 | 179,353 (0%) | 0% | 30.5 | 299,890 | Common Stock |
| Collegium Pharmaceutical Inc | Shirley R. Kuhlmann | EVP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.34 per share. | 10 Jan 2025 | 27,500 | 146,684 (0%) | 0% | 21.3 | 586,850 | Common Stock |
| Collegium Pharmaceutical Inc | Shirley R. Kuhlmann | EVP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jan 2025 | 27,500 | 0 | - | - | Stock Option (Right to Purchase) | |
| Collegium Pharmaceutical Inc | Shirley R. Kuhlmann | EVP and General Counsel | Sale of securities on an exchange or to another person at price $ 32.87 per share. | 10 Jan 2025 | 21,400 | 125,284 (0%) | 0% | 32.9 | 703,407 | Common Stock |
| Collegium Pharmaceutical Inc | Shirley R. Kuhlmann | EVP and General Counsel | Sale of securities on an exchange or to another person at price $ 33.64 per share. | 10 Jan 2025 | 6,100 | 119,184 (0%) | 0% | 33.6 | 205,220 | Common Stock |
| Collegium Pharmaceutical Inc | Shirley R. Kuhlmann | EVP and General Counsel | 05 Sep 2024 | 16,848 | 122,561 (0%) | 0% | 38.2 | 643,257 | Common Stock | |
| Collegium Pharmaceutical Inc | Shirley R. Kuhlmann | EVP and General Counsel | 05 Sep 2024 | 2,400 | 120,161 (0%) | 0% | 39.1 | 93,941 | Common Stock | |
| Collegium Pharmaceutical Inc | Shirley R. Kuhlmann | EVP and General Counsel | 05 Sep 2024 | 977 | 119,184 (0%) | 0% | 37.5 | 36,594 | Common Stock | |
| Collegium Pharmaceutical Inc | Shirley R. Kuhlmann | EVP and General Counsel | 03 Jun 2024 | 24,300 | 140,109 (0%) | 0% | 32.5 | 790,926 | Common Stock | |
| Collegium Pharmaceutical Inc | Shirley R. Kuhlmann | EVP and General Counsel | 03 Jun 2024 | 700 | 139,409 (0%) | 0% | 33.2 | 23,254 | Common Stock | |
| Collegium Pharmaceutical Inc | Kuhlmann Shirley R. | EVP and General Counsel | 12 Feb 2024 | 43,400 | 162,918 (0%) | 0% | 0 | Common Stock | ||
| Collegium Pharmaceutical Inc | R. Kuhlmann Shirley | EVP and General Counsel | 12 Feb 2024 | 33,247 | 196,165 (0%) | 0% | 0 | Common Stock | ||
| Collegium Pharmaceutical Inc | R. Kuhlmann Shirley | EVP and General Counsel | 12 Feb 2024 | 21,146 | 175,019 (0%) | 0% | 33.7 | 712,620 | Common Stock | |
| Collegium Pharmaceutical Inc | Shirley R. Kuhlmann | EVP and General Counsel | 12 Feb 2024 | 10,610 | 164,409 (0%) | 0% | 33.7 | 357,557 | Common Stock | |
| Collegium Pharmaceutical Inc | Shirley R. Kuhlmann | EVP and General Counsel | 26 Jun 2023 | 16,621 | 120,881 (0%) | 0% | 21.7 | 359,918 | Common Stock | |
| Collegium Pharmaceutical Inc | Shirley R. Kuhlmann | EVP and General Counsel | 26 Jun 2023 | 1,363 | 119,518 (0%) | 0% | 22.5 | 30,715 | Common Stock | |
| Collegium Pharmaceutical Inc | Shirley R. Kuhlmann | EVP and General Counsel | 10 Feb 2023 | 48,125 | 157,620 (0%) | 0% | 0 | Common Stock | ||
| Collegium Pharmaceutical Inc | Shirley R. Kuhlmann | EVP and General Counsel | 10 Feb 2023 | 25,739 | 183,359 (0%) | 0% | - | Common Stock | ||
| Collegium Pharmaceutical Inc | Shirley R. Kuhlmann | EVP and General Counsel | 10 Feb 2023 | 21,811 | 137,502 (0%) | 0% | 26.9 | 586,280 | Common Stock | |
| Collegium Pharmaceutical Inc | Shirley R. Kuhlmann | EVP and General Counsel | 10 Feb 2023 | 16,291 | 167,068 (0%) | 0% | 26.7 | 435,784 | Common Stock | |
| Collegium Pharmaceutical Inc | Shirley R. Kuhlmann | EVP and General Counsel | 10 Feb 2023 | 7,755 | 159,313 (0%) | 0% | 26.7 | 207,446 | Common Stock | |
| Collegium Pharmaceutical Inc | Shirley R. Kuhlmann | EVP and General Counsel | 15 Sep 2022 | 38,589 | 109,495 (0%) | 0% | 18.1 | 697,303 | Common Stock | |
| Collegium Pharmaceutical Inc | Shirley R. Kuhlmann | EVP and General Counsel | 11 Aug 2022 | 300 | 148,084 (0%) | 0% | 20.0 | 6,003 | Common Stock | |
| Collegium Pharmaceutical Inc | Shirley R. Kuhlmann | EVP and General Counsel | 16 Mar 2022 | 734 | 148,384 (0%) | 0% | 19.0 | 13,939 | Common Stock | |
| Collegium Pharmaceutical Inc | Shirley R. Kuhlmann | EVP and General Counsel | 10 Feb 2022 | 56,700 | 145,956 (0%) | 0% | 0 | Common Stock | ||
| Collegium Pharmaceutical Inc | Shirley R. Kuhlmann | EVP and General Counsel | 10 Feb 2022 | 14,341 | 160,297 (0%) | 0% | - | Common Stock | ||
| Collegium Pharmaceutical Inc | Shirley R. Kuhlmann | EVP and General Counsel | 10 Feb 2022 | 6,967 | 153,330 (0%) | 0% | 17.6 | 122,828 | Common Stock | |
| Collegium Pharmaceutical Inc | Shirley R. Kuhlmann | EVP and General Counsel | 10 Feb 2022 | 4,212 | 149,118 (0%) | 0% | 17.6 | 74,258 | Common Stock | |
| Collegium Pharmaceutical Inc | Shirley R. Kuhlmann | EVP and General Counsel | 16 Sep 2021 | 734 | 89,256 (0%) | 0% | 19.7 | 14,438 | Common Stock | |
| Collegium Pharmaceutical Inc | Shirley R. Kuhlmann | EVP and General Counsel | 10 May 2021 | 7,000 | 89,990 (0%) | 0% | 22.8 | 159,390 | Common Stock | |
| Collegium Pharmaceutical Inc | Shirley R. Kuhlmann | EVP and General Counsel | 16 Mar 2021 | 734 | 96,990 (0%) | 0% | 24.7 | 18,122 | Common Stock | |
| Collegium Pharmaceutical Inc | Shirley R. Kuhlmann | EVP and General Counsel | 10 Feb 2021 | 3,695 | 97,724 (0%) | 0% | 25.9 | 95,885 | Common Stock | |
| Collegium Pharmaceutical Inc | Shirley R. Kuhlmann | EVP and General Counsel | 10 Feb 2021 | 2,163 | 101,419 (0%) | 0% | 26.0 | 56,130 | Common Stock | |
| Collegium Pharmaceutical Inc | Shirley R. Kuhlmann | EVP and General Counsel | 19 Jan 2021 | 45,360 | 102,891 (0%) | 0% | 0 | Common Stock | ||
| Collegium Pharmaceutical Inc | Shirley R. Kuhlmann | EVP and General Counsel | 19 Jan 2021 | 6,772 | 109,663 (0%) | 0% | - | Common Stock | ||
| Collegium Pharmaceutical Inc | Shirley R. Kuhlmann | EVP and General Counsel | 19 Jan 2021 | 6,081 | 103,582 (0%) | 0% | 24.4 | 148,680 | Common Stock | |
| Collegium Pharmaceutical Inc | Shirley R. Kuhlmann | EVP and General Counsel | 15 Oct 2020 | 7,060 | 57,531 (0%) | 0% | 20.8 | 146,989 | Common Stock | |
| Collegium Pharmaceutical Inc | Shirley R. Kuhlmann | EVP and General Counsel | 16 Sep 2020 | 734 | 64,591 (0%) | 0% | 19.3 | 14,188 | Common Stock |